Sign in
Not yet recruitingPhase 3

A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer

Key facts

Who runs it
Queensland Centre for Gynaecological Cancer
Where
Australia9 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 3
People taking part
640 people, planned
Started
1 Jun 2026
Expected to end
31 Dec 2035
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • High-resolution bilateral groin ultrasound monitoring
Record updated
24 March 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Females, over 18 years, with histologically confirmed SCC or adenocarcinoma of the vulva
  • Clinically stage 1b or 2 on medical imaging (CT or MRI scan of pelvis, abdomen, and chest), without evidence of regional or distant metastatic disease
  • Willing and able to undergo IFL/SNB according to local clinical practice management guidelines
  • Willing and able to comply with all study requirements, timing and/or nature of required assessments
  • Signed written informed consent
  • Negative (serum or urine) pregnancy (BHCG) test ≤ 30 days of surgery ONLY in pre-menopausal women and women < 2 years after the onset of menopause

Who cannot take part

  • Serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator)
  • Women with non-invasive vulvar conditions (e.g. non-invasive non-mammary Paget's disease)
  • Clinical or medical imaging evidence of regional and/or distant metastatic disease
  • Other prior malignancies <5 years before inclusion, except for successfully treated keratinocyte skin cancers, or ductal carcinoma in situ
  • Estimated life expectancy of ≤6 months

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is a phase III, open label, multicentre, three-group, randomised clinical trial. The primary aim of this study is to determine whether intensive groin ultrasound monitoring (1) is effective and safe to replace invasive groin lymph node dissection (LND) to manage vulvar cancer, (2) decreases the morbidity associated with vulvar cancer surgery, and (3) is cost effective.

The 3 groups in the trial

  • Participants with normal/negative baseline groin ultrasounds - Intervention GroupTreatment being tested

    Surgical removal of primary tumour and serial high-resolution bilateral groin ultrasound monitoring every 2 months for 12 months, and at month 15 and month 18, with clinical examination at 8 weeks, 4 months, 8 months, 12 months, 15 months, and 18 months (n=360).

    Treatment: High-resolution bilateral groin ultrasound monitoring

  • Participants with normal/negative baseline groin ultrasounds - Standard GroupNo study treatment, for comparison

    Surgical removal of primary tumour and upfront full groin lymph node dissection (LND) or sentinel node biopsy (SNB) based on clinician choice (according to local clinical practice management guidelines) (n=120).

  • Participants with suspicious/indeterminate baseline groin ultrasound - Standard TreatmentNo study treatment, for comparison

    Participants with suspicious/indeterminate baseline groin ultrasound (third group) will receive an upfront full groin LND or SNB, consistent with the current standard treatment, according to local clinical practice management guidelines (n=160).

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
24 March 2026